The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population

The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population

Background: In the United States (US), colorectal cancer (CRC) is the second leading cause of cancer-related deaths. With the majority of the US population covered by employer-based health plans, employers can play a critical role in increasing CRC screening adherence, which may help avert CRC-relat...

Full description

Bibliographic Details
Main Authors: Joanne M Hathway, Lesley-Ann Miller-Wilson, Abhishek Sharma, Ivar S Jensen, Weiyu Yao, Sajjad Raza, Philip D Parks, Milton C Weinstein
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Market Access & Health Policy
Subjects:
colorectal cancer
screening
employer-based insurance
budget impact
Online Access:http://dx.doi.org/10.1080/20016689.2021.1948670

Internet

http://dx.doi.org/10.1080/20016689.2021.1948670

Similar Items